Ensol Biosciences Market Cap

Ensol Biosciences has a market cap or net worth of 192.35 billion as of April 24, 2026. Its market cap has decreased by -33.47% in one year.

Market Cap

192.35B

Enterprise Value

n/a

Revenue

537.46M

Ranking

n/a

PE Ratio

n/a

Stock Price

14,200.00

Market Cap Chart

Since September 10, 2018, Ensol Biosciences's market cap has increased from 106.21B to 192.35B, an increase of 81.12%. That is a compound annual growth rate of 8.10%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2026	192.35B	9.55%
Dec 30, 2025	175.59B	-10.18%
Dec 30, 2024	195.49B	264.72%
Dec 28, 2023	53.60B	-23.21%
Dec 29, 2022	69.80B	-47.06%
Dec 30, 2021	131.85B	5.52%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Sep 10, 2018	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Bio Solution	284.36B
TiumBio	268.39B
ABION	235.16B
Genome & Company	214.24B
ISU Abxis	196.91B
Prestige Biologics	192.83B
ViGenCell	151.49B
QuadMedicine	147.89B

Market Cap Rankings